Cargando…

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use

Polycystic liver disease (PLD) is a common extrarenal complication of autosomal dominant polycystic kidney disease (ADPKD), which causes compression-related syndrome and ultimately leads to liver dysfunction. Tolvaptan, a V2 receptor antagonist, is widely used to protect kidney function in ADPKD but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizuno, Hiroki, Sekine, Akinari, Suwabe, Tatsuya, Ikuma, Daisuke, Yamanouchi, Masayuki, Hasegawa, Eiko, Sawa, Naoki, Ubara, Yoshifumi, Hoshino, Junichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853523/ https://www.ncbi.nlm.nih.gov/pubmed/35176098 http://dx.doi.org/10.1371/journal.pone.0264065

Ejemplares similares

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017)

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
por: Kunizawa, Kyohei, et al.
Publicado: (2018)

Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation
por: Suwabe, Tatsuya, et al.
Publicado: (2023)

Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease
por: Hasegawa, Eiko, et al.
Publicado: (2016)

Development of an enterocutaneous fistula from an intestinal perforation in a patient with autosomal dominant polycystic kidney disease
por: Nakayama, Yuki, et al.
Publicado: (2022)

A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Successful peficitinib addition on anti-MDA5 antibody-positive dermatomyositis refractory to triple therapy and glucocorticoid reduction
por: Oba, Yuki, et al.
Publicado: (2022)

Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control
por: Suwabe, Tatsuya, et al.
Publicado: (2021)

Renal Transcatheter Arterial Embolization for ADPKD
por: Oda, Yasuhiro, et al.
Publicado: (2020)

Renal Squamous Cell Carcinoma-related Polymyositis in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Terakawa, Kanako, et al.
Publicado: (2021)

Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
por: Yoshimura, Yusuke, et al.
Publicado: (2022)

Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis
por: Sawamura, Masato, et al.
Publicado: (2022)

Can Takayasu Arteritis Cause Hydronephrosis?
por: Terakawa, Kanako, et al.
Publicado: (2023)

Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study
por: Suwabe, Tatsuya, et al.
Publicado: (2013)

Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
por: Ikuma, Daiuske, et al.
Publicado: (2019)

PKD1-associated autosomal dominant polycystic kidney disease with glomerular cysts presenting with nephrotic syndrome caused by focal segmental glomerulosclerosis
por: Oda, Yasuhiro, et al.
Publicado: (2019)

Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence
por: Suwabe, Tatsuya, et al.
Publicado: (2021)

Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis
por: Sawamura, Masato, et al.
Publicado: (2020)

Tocilizumab Attenuates Anti-neutrophil Cytoplasmic Antibody-associated Nephritis Occurring during Abatacept and Adalimumab Therapy for Rheumatoid Arthritis
por: Yoshimura, Yusuke, et al.
Publicado: (2022)

Renal epithelial and stromal tumor with a multiple cystic lesion localized in the upper portion of the right kidney
por: Sawamura, Masato, et al.
Publicado: (2020)

Kidney Histology Findings in a Patient with Autosomal Dominant Tubulointerstitial Kidney Disease Subtype Hepatocyte Nuclear Factor 1β
por: Nakayama, Yuki, et al.
Publicado: (2022)

Endothelial Damage-dominant Nephritis Related to IgA Vasculitis after 11 Years' Use of Infliximab for Rheumatoid Arthritis
por: Fukuda, Makoto, et al.
Publicado: (2022)

Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine
por: Hara, Risa, et al.
Publicado: (2022)

A Half-Century Dialysis Survivor: Clinical and Autopsy Findings
por: Okubo, Noto, et al.
Publicado: (2023)

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD
por: Higashihara, Eiji, et al.
Publicado: (2021)

Immunoglobulin G4-related Hepatopathy after COVID-19 Vaccination
por: Kuno, Masahiro, et al.
Publicado: (2023)

The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome
por: Mizuno, Hiroki, et al.
Publicado: (2020)

Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis
por: Sawamura, Masato, et al.
Publicado: (2021)

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease
por: Sumida, Keiichi, et al.
Publicado: (2013)

Characteristic Renal Histology of a 81-Year-Old Patient with a 30-Year History of Diabetes Mellitus: A Case Report
por: Shima, Natsuki, et al.
Publicado: (2020)

Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders
por: Oshima, Yoichi, et al.
Publicado: (2020)

Denosumab for dialysis patients with osteoporosis: A cohort study
por: Kunizawa, Kyohei, et al.
Publicado: (2020)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Raina, Rupesh, et al.
Publicado: (2022)

Tolvaptan in ADPKD Patients With Very Low Kidney Function
por: Torres, Vicente E., et al.
Publicado: (2021)

Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer
por: Yoshimura, Yusuke, et al.
Publicado: (2022)

Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions
por: Nakayama, Yuki, et al.
Publicado: (2022)

Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis
por: Yabuuchi, Junko, et al.
Publicado: (2017)

Onion Skin Lesion of the Renal Small Artery in a Patient With Polymyositis and Hemolytic Uremic Syndrome
por: Kurihara, Shigekazu, et al.
Publicado: (2022)

Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients
por: Bargagli, Matteo, et al.
Publicado: (2021)

Fabry Disease on Peritoneal Dialysis with Cardiac Involvement
por: Koga-Kobori, Sayako, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fni0rbov7frh0dhuo919aefsq6